loader
Please Wait
Applying Filters...

Looking for 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one? Find Disintegrants & Superdisintegrants used in 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one to address drug delivery challenges on PharmaCompass.

Menu
$ API Ref.Price (USD/KG) : 1,792Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Jai Radhe Sales

02 5Gangwal Healthcare

03 6Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

04 2DFE Pharma

05 4Gangwal Chemicals

06 1Ingredion Pharma Solutions

07 1Pharmatrans-Sanaq

08 3Pluviaendo

09 1Prachin Chemical

10 4Roquette

11 2Shanghai Shenmei Pharmaceutical Technology Co., Ltd

12 2Sigachi Industries

13 3Ulanqab Kema New Material

14 4Vasa Pharmachem

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Brand : SALLYSO™

Applications : Sallyso (Croscarmellose Sodium) is used as a disintegrating agent in tablets, capsules & granules for enhancing API dissolution and bioavailability.

Pharmacopoeia Ref : IP/BP/EP/USP-NF

Technical Specs : Sallyso 0.5 to 3.0%

Grade : Oral

arrow

04

arrow
2024 ACI Convention
Not Confirmed

06

arrow
2024 ACI Convention
Not Confirmed

07

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

08

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

09

arrow
2024 ACI Convention
Not Confirmed

10

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

11

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

13

arrow
2024 ACI Convention
Not Confirmed

18

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

19

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : F-MELT TYPE M

Applications : F-Melt Type M is used in various dosage forms like orally disintegrating tablets (ODTs), sachets, dispersible tablets, chewable tablets and sublingual formulations.

Pharmacopoeia Ref : Conforms to Japanese Pharmaceutical Excipients. All components meet USP-NF, JP and EP.

Technical Specs : Not Available

Grade : Oral

arrow
blank

20

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : F-MELT TYPE C

Applications : F-Melt Type C is a pharmaceutical excipient used in oral dosage forms like orally disintegrating tablets, sachets, dispersible tablets, chewable tablets and sublingual tablets.

Pharmacopoeia Ref : Conforms to Japanese Pharmaceutical Excipients. All components meet USP-NF, JP, EP. US DMF Type IV filed.

Technical Specs : Not Available

Grade : Oral

arrow
blank